182 related articles for article (PubMed ID: 9569006)
1. Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen.
Rivera-Gonzalez R; Petersen DN; Tkalcevic G; Thompson DD; Brown TA
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):13-24. PubMed ID: 9569006
[TBL] [Abstract][Full Text] [Related]
2. Induction of UO-44 gene expression by tamoxifen in the rat uterus and ovary.
Huynh H; Ng CY; Lim KB; Ong CK; Ong CS; Tran E; Tuyen Nguyen TT; Chan TW
Endocrinology; 2001 Jul; 142(7):2985-95. PubMed ID: 11416020
[TBL] [Abstract][Full Text] [Related]
3. Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus.
Diel P; Walter A; Fritzemeier KH; Hegele-Hartung C; Knauthe R
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):363-73. PubMed ID: 8541233
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the short-term effects of a novel selective estrogen receptor modulator, ospemifene, and raloxifene and tamoxifen on rat uterus.
Zheng H; Kangas L; Härkönen PL
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):143-56. PubMed ID: 15084346
[TBL] [Abstract][Full Text] [Related]
5. Common mechanism for the estrogen agonist and antagonist activities of droloxifene.
Grasser WA; Pan LC; Thompson DD; Paralkar VM
J Cell Biochem; 1997 May; 65(2):159-71. PubMed ID: 9136075
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
Sato M; Rippy MK; Bryant HU
FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus.
Reed CA; Berndtson AK; Nephew KP
Anticancer Drugs; 2005 Jun; 16(5):559-67. PubMed ID: 15846122
[TBL] [Abstract][Full Text] [Related]
8. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form.
Song WC; Deng C; Raszmann K; Moore R; Newbold R; McLachlan JA; Negishi M
J Immunol; 1996 Nov; 157(9):4166-72. PubMed ID: 8892654
[TBL] [Abstract][Full Text] [Related]
9. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.
Qu Q; Zheng H; Dahllund J; Laine A; Cockcroft N; Peng Z; Koskinen M; Hemminki K; Kangas L; Väänänen K; Härkönen P
Endocrinology; 2000 Feb; 141(2):809-20. PubMed ID: 10650964
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of tamoxifen and ICI 182 780 on estrogen-induced calbindin-D 9k gene expression in the uterus and in primary culture of myometrial cells.
Blin C; L'Horset F; Leclerc T; Lambert M; Colnot S; Thomasset M; Perret C
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):1-7. PubMed ID: 7577712
[TBL] [Abstract][Full Text] [Related]
11. A novel estrogen-enhanced transcript identified in the rat uterus by differential display.
Everett LM; Li A; Devaraju G; Caperell-Grant A; Bigsby RM
Endocrinology; 1997 Sep; 138(9):3836-41. PubMed ID: 9275072
[TBL] [Abstract][Full Text] [Related]
12. Protooncogene, growth factor, growth factor receptor, and estrogen and progesterone receptor gene expression in the immature rat uterus after treatment with estrogen and tamoxifen.
Bhattacharyya N; Ramsammy R; Eatman E; Hollis VW; Anderson WA
J Submicrosc Cytol Pathol; 1994 Apr; 26(2):147-62. PubMed ID: 8019941
[TBL] [Abstract][Full Text] [Related]
13. No loss of estrogenic or anti-estrogenic activity after demethylation of droloxifene (3-OH-tamoxifen).
Löser R; Seibel K; Eppenberger U
Int J Cancer; 1985 Dec; 36(6):701-3. PubMed ID: 4066073
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus.
Zierau O; O'Sullivan J; Morrissey C; McDonald D; Wünsche W; Schneider MR; Tenniswood MP; Vollmer G
Endocr Relat Cancer; 2004 Dec; 11(4):823-30. PubMed ID: 15613455
[TBL] [Abstract][Full Text] [Related]
15. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
16. Estrogen regulates the stage-specific expression of kidney androgen-regulated protein in rat uterus during reproductive cycle and pregnancy.
Runic R; Zhu LJ; Crozat A; Bagchi MK; Catterall JF; Bagchi IC
Endocrinology; 1996 Feb; 137(2):729-37. PubMed ID: 8593824
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.
Huynh HT; Pollak M
Cancer Res; 1993 Dec; 53(23):5585-8. PubMed ID: 8242606
[TBL] [Abstract][Full Text] [Related]
18. Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen, and xenoestrogen.
Das SK; Tan J; Johnson DC; Dey SK
Endocrinology; 1998 Jun; 139(6):2905-15. PubMed ID: 9607801
[TBL] [Abstract][Full Text] [Related]
19. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
[TBL] [Abstract][Full Text] [Related]
20. In vivo regulation of syndecan-3 expression in the rat uterus by 17 beta-estradiol.
Russo LA; Calabro SP; Filler TA; Carey DJ; Gardner RM
J Biol Chem; 2001 Jan; 276(1):686-92. PubMed ID: 11024013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
